PRT3789
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PRT3789, covering 2025-10-16 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 2]